Hi Eqz & All,
Here is an interview with Kris Sterkens, Group Chairman of EMEA Janssen, that you may find interesting on the outlook of how this Pharma will move forward & their business model/plan.
Please keep in mind it’s general, so you can’t infer too much, but was a bit of an “ahaa” moment for me listening to this in relation to the potential of PIQ diagnostics & PromarkerD:
http://www.pharmexec.com/conversation-kris-sterkens-group-chairman-emea-janssen
Best wishes
Ann: Appendix 4C - March 2019 Quarterly Report, page-45
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.015(4.92%) |
Mkt cap ! $47.42M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 31.0¢ | 28.5¢ | $191.2K | 643.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 53694 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 51000 | 2 |
View Market Depth
| Last trade - 15.36pm 26/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |